Skip to content
Assyro AI
FDA Orange Book · active-ingredient family

Chromic chloride

Chromic chloride: 2 brands, 1 generic; first approved Jun 26, 1986; generic available.

Generic availableHas discontinued products
Generic status & protection

Generic available: 1 ANDA application approved.

Brands (NDA)
2
Generics (ANDA)
1
Listed patents
0
Presentations
3

Brand (NDA) products

Originator applications
  • NDA 0189611986
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.004MG CHROMIUM/MLINJECTABLEINJECTIONRxAP
  • CHROMIC CHLORIDE
    NDA 0192711987
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.004MG CHROMIUM/MLINJECTABLEINJECTIONDiscontinued

Generic (ANDA) products (1)

Abbreviated applications
  • CHROMIC CHLORIDE
    ANDA 2185382024
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.004MG CHROMIUM/MLINJECTABLEINJECTIONRxAP

Listed patents

Orange Book patent file

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Approval history

FDA approval span
First approval
40 yr 9 mo ago
Most recent approval
1 yr 9 mo ago

Approvals span 1986–2024 across 3 FDA applications.

Brand (NDA) 267%
Generic (ANDA) 133%

Chromic chloride: frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Related FDA reference tools

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.